A Study of Brenipatide in Participants With Opioid Use Disorder

Clinical trial NCT07420283 · RECRUITING

Trial details

NCT number: NCT07420283
Sponsor: Eli Lilly and Company
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Opioid Use Disorder

Start date: 2026-02-13
Primary completion: 2028-03-01
Enrollment: 465

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.